ClinicalTrials.gg
CompletedNCT02813733CATHYUpdated Jun 27, 2016

Determinants of Thyroid Surgery Outcomes

An observational study in Thyroid Disease, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2016-06-27.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,500
Sex
All
01

Study summary

In a large prospective cross-sectional study, the investigators aimed to identify the determinants of thyroid surgery outcomes and quantify the relative influence of preoperative and intraoperative factors. For this purpose, the investigators considered the interplay of several characteristics specific to surgeons, patients, and surgical procedures.

02

Conditions studied

  • Thyroid Disease

Browse trials for

Keywords

  • thyroid surgery
  • surgical outcomes
  • patient safety
  • healthcare quality
  • surgeons performance
03

In context

Thyroid Diseases

976 studies on the registry are indexed under Thyroid Diseases; 197 are open to participants now.

This study's enrollment of 3,500 is above the median of 155 across 387 observational studies indexed under Thyroid Diseases.

Browse Thyroid Diseases studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,854 studies on the registry; 441 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients who underwent a thyroid procedure during study period in 5 high volume referral centers in France were eligible for inclusion.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- All patients who underwent a thyroid procedure between April 2008 and July 2008.

Exclusion criteria

Exclusion Criteria:

- Participation refusal

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,500 participants (actual)
Patient registry
No

Groups and cohorts

  • Thyroid surgery

    All patients who underwent a thyroid procedure in 5 high volume referral centers in France were eligible for inclusion.

    Procedure: Thyroid surgery

Interventions

  • ProcedureThyroid surgery

    Thyroidectomies performed by all surgeons in 5 academic hospitals in France.

06

What researchers measure

Primary outcomes

  1. Recurrent laryngeal nerve palsy

    Systematic postoperative screening by laryngoscopy

    Time frame: During inpatient stay and at 6 months following surgery

Secondary outcomes

  1. Secondary hypoparathyroidism

    Systematic postoperative screening based on hypocalcaemia \< 2 mmoL/l or vitaminocalcic substitution

    Time frame: During inpatient stay and at 6 months following surgery

07

Study locations

1 site
  • Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet
    Pierre-Bénite, 69310, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02813733
Responsible party
Sponsor
First posted
Jun 27, 2016
Start date
Apr 2008
Primary completion
Dec 2009
Completion
Jan 2016
Last update
Jun 27, 2016

Study contacts

Jean-Christophe Lifante
principal investigator · Hospices Civils de Lyon

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion